Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Synthesis and preclinical evaluation of [C-11]LR111 and [F-18]EW-7197 as PET tracers of the activin-receptor like kinase-5

Autor: Rotteveel, L., Kurakula, K., Kooijman, E.J.M., Schuit, R.C., Verlaan, M., Schreurs, M., Beaino, W., Dinther, M.A.H. van, Dijke, P. ten, Lammertsma, A.A., Poot, A.J., Bogaard, H.J., Windhorst, A.D.

Publikováno v: Nuclear Medicine and Biology, 112-113, 9-19. Elsevier Inc.
Rotteveel, L, Kurakula, K, Kooijman, E J M, Schuit, R C, Verlaan, M, Schreurs, M, Beaino, W, van Dinther, M A H, ten Dijke, P, Lammertsma, A A, Poot, A J, Bogaard, H J & Windhorst, A D 2022, ' Synthesis and preclinical evaluation of [ 11 C]LR111 and [ 18 F]EW-7197 as PET tracers of the activin-receptor like kinase-5 ', Nuclear Medicine and Biology, vol. 112-113, pp. 9-19 . https://doi.org/10.1016/j.nucmedbio.2022.05.003
Nuclear Medicine and Biology, 112, 9-19. ELSEVIER SCIENCE INC

The transforming growth factor β (TGFβ) pathway plays a complex role in cancer biology, being involved in both tumour suppression as well as promotion. Overactive TGFβ signalling has been linked to multiple diseases, including cancer, pulmonary ar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2c5c74b3c0f5473298d667076d0cc04
https://hdl.handle.net/1887/3562166

Corrigendum to 'SSP-27: 89Zr-immuno-PET of a novel bispecific amyloid β monoclonal antibody reveals improved and high specific brain uptake' [Nucl Med Biol (2020) Volumes 96–97, Supplement. S30-S31] (Nuclear Medicine and Biology (2021) 96–97(S) (S1–S114), (S0969805121X00042))

Autor: Stergiou, N., Wünsche, E. T., Mes, I., Schreurs, M., Verlaan, M., Kooijman, E. J. M., Windhorst, A. D., Dongen, G. A. M. S., Helboe, L., Vergo, S., Christensen, S., Asuni, A., Jensen, A., Bang-Andersen, B., Vugts, D. J., Beaino, W.

Publikováno v: Nuclear Medicine and Biology. Elsevier Inc.
Stergiou, N, Wünsche, E T, Mes, I, Schreurs, M, Verlaan, M, Kooijman, E J M, Windhorst, A D, Dongen, G A M S, Helboe, L, Vergo, S, Christensen, S, Asuni, A, Jensen, A, Bang-Andersen, B, Vugts, D J & Beaino, W 2021, ' Corrigendum to “SSP-27: 89Zr-immuno-PET of a novel bispecific amyloid β monoclonal antibody reveals improved and high specific brain uptake” [Nucl Med Biol (2020) Volumes 96–97, Supplement. S30-S31] (Nuclear Medicine and Biology (2021) 96–97(S) (S1–S114), (S0969805121X00042)) ', Nuclear Medicine and Biology . https://doi.org/10.1016/j.nucmedbio.2021.05.006

The authors regret . The authors would like to apologise for any inconvenience caused.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::31f8d957822e8ab24d242ee036768a2b
https://research.vumc.nl/en/publications/3f868859-8c02-4470-a3af-8806b2d6ce78

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Purinergic receptor P2Y12: a potential target for PET imaging of neuroinflammation in multiple sclerosis and EAE

Autor: Beaino, W., Janssen, B., Kooij, G., van der Pol, S., Windhorst, A. D., de Vries, H. E.

Publikováno v: GLIA, 65, E478-E479. John Wiley and Sons Inc.
Beaino, W, Janssen, B, Kooij, G, van der Pol, S, Windhorst, A D & de Vries, H E 2017, ' Purinergic receptor P2Y12: a potential target for PET imaging of neuroinflammation in multiple sclerosis and EAE ', GLIA, vol. 65, pp. E478-E479 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::027af20b39b008713738130697f5d57f
https://research.vumc.nl/en/publications/01a7dff6-e699-4036-9185-fe956cf03277